Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency through Suppression of Erythroid Heme Synthesis
Publication date
2019-07
Authors
Neeleman, Rochus A
Van Beers, Eduard J.
Friesema, Edith C
Koole-Lesuis, Rita
van der Pol, Willem L
Wilson, J H Paul
Langendonk, Janneke G
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
Abstract
We present a case of delta-aminolevulinic acid dehydratase-porphyria (ADP) who was successfully treated by suppressing bone-marrow production of toxic heme precursors. Together with supporting evidence from earlier cases, it is likely ADP has both hepatic and erythroid origins. This article is protected by copyright. All rights reserved.
Keywords
Hepatology, Journal Article
Citation
Neeleman, R A, van Beers, E J, Friesema, E C, Koole-Lesuis, R, van der Pol, W L, Wilson, J H P & Langendonk, J G 2019, 'Clinical Remission of Delta-Aminolevulinic Acid Dehydratase Deficiency through Suppression of Erythroid Heme Synthesis', Hepatology (Baltimore, Md.), vol. 70, no. 1, pp. 434-436. https://doi.org/10.1002/hep.30543